Crowdonomics
WatchlistPortfolio
All companies

RMR Laboratories

Operating

G&G Laboratories, Inc

Biotech · Dover, DE · Founded 2017

Veteran-founded
Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$2,786,479
Crowd $786K · Private $2.0M · 2 rounds since 2017

Financials

FY2015–FY2018 · from SEC filings · hover any figure for its source
$0
2015
$0
2016
$0
2017
$0
2018
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2015 reviewed*
FY2016 reviewed*
FY2017
FY2018
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
Net income
$0
$0
$0
$0
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$0
$0
$0
Accounts receivable
$0
$0
$0
$0
Total assets
$0
$0
$0
$0
Short-term debt
$0
$0
$0
$0
Long-term debt
$0
$0
$0
$0
Total liabilities
$0
$0
$0
$0
Other
Headcount
—
2
—
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Rule 506(b) · Debt · Jan 2019Closed
Raised $2MInvestors 1
Reg CF · SAFE · Nov 2017Closedvia Republic
Raised $786.5K / $1.1MInvestors 951

Team

2 people
Michael Lui
CEO
James Buck Jordan
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 1 of 9 annual reports (FY2017–FY2025)

951 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-TRApr 24, 20190001717904-19-000004
    EDGAR
  • Form DMar 28, 20190001717904-19-000002
    EDGAR
  • Form C-UMay 7, 20180001717904-18-000002
    EDGAR
  • Form C-ARMay 1, 20180001717904-18-000001
    EDGAR
  • Form CNov 6, 20170001717904-17-000001
    EDGAR
Source: SEC EDGARCIK 0001717904DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.